Relationship between abnormal microvolt T-wave alternans and poor glycemic control in type 2 diabetic patients

PACE - Pacing and Clinical Electrophysiology

Volumn 30, Issue 10, 2007, Pages 1267-1272

  Molon, Giulio ^a   Costa, Alessandro ^a   Bertolini, Lorenzo ^a   Zenari, Luciano ^a   Arcaro, Guido ^a   Barbieri, Enrico ^a   Targher, Giovanni ^a,b  

^a SACRO CUORE DON CALABRIA HOSPITAL   (Italy)

^b UNIVERSITY HOSPITAL OF VERONA   (Italy)

Author keywords

Arrhythmias; Glycemic control; Microvolt T wave alternans; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; LIPID;

ADULT; AGE; AGED; ARTICLE; BICYCLE ERGOMETER; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE DURATION; EXERCISE; FEMALE; GENDER; GLYCEMIC CONTROL; HEART ARRHYTHMIA; HEART RATE VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; QT INTERVAL; RISK ASSESSMENT; T WAVE;

AGED; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS;

EID: 34848895709     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2007.00849.x     Document Type: Article

References (23)

1. Narayan SM. T-wave alternans and the susceptibility to ventricular arrhythmias. J Am Coll Cardiol 2006 47 : 269 281.
2. Rosenbaum DS, Jackson LE, Smith JM, Garan H, Ruskin JN, Cohen RJ. Electrical alternans and vulnerability to ventricular arrhythmias. N Engl J Med 1994 330 : 235 241.
3. Estes NA III., Michaud G, Zipes DP, El-Sherif N, Venditti FJ, Rosenbaum DS, Albrecht P, et al. Electrical alternans during rest and exercise as predictors of vulnerability to ventricular arrhythmias. Am J Cardiol 1997 80 : 1314 1318.
4. Kitamura H, Ohnishi Y, Okajima K, Ishida A, Galeano E, Adachi K, Yokoyama M. Onset heart rate of microvolt-level T-wave alternans provides clinical and prognostic value in non-ischemic dilated cardiomyopathy. J Am Coll Cardiol 2002 39 : 295 300.
5. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: Results from a prospective observational study. J Am Coll Cardiol 2003 41 : 2220 2224.
6. Armoundas AA, Osaka M, Mela T, Rosenbaum DS, Ruskin JN, Garan H, Cohen RJ. T-wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias. Am J Cardiol 1998 82 : 1127 1129.
7. Grimm W, Liedtke J, Muller HH. Prevalence of potential non-invasive arrhythmia risk predictors in healthy, middle-aged persons. Ann Noninvasive Electrocardiol 2003 8 : 37 46.
8. Weber S, Tillmanns H, Waldecker B. Prevalence of T wave alternans in healthy subjects. Pacing Clin Electrophysiol 2003 26 : 49 52.
9. Bloomfield DM, Bigger JT, Steinman RC, Namerow PB, Parides MK, Curtis AB, Kaufman ES, et al. Microvolt T-wave alternans and the risk of death or sustained ventricular arrhythmias in patients with left ventricular dysfunction. J Am Coll Cardiol 2006 47 : 456 463.
10. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung ES, et al. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy. J Am Coll Cardiol 2006 47 : 1820 1827.
11. Chow T, Kereiakes DJ, Bartone C, Booth T, Schloss EJ, Waller T, Chung E, et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 2007 49 : 50 58.
12. Marfella R, Nappo F, De Angelis L, Siniscalchi M, Rossi F, Giugliano D. The effect of acute hyperglycaemia on QTc duration in healthy man. Diabetologia 2000 43 : 571 575.
13. Veglio M, Chinaglia A, Cavallo Perin P. The clinical utility of QT interval assessment in diabetes. Diabetes Nutr Metab 2000 13 : 356 365.
14. Marfella R, Rossi F, Giugliano D. Hyperglycemia and QT interval: Time for re-evaluation. Diabetes Nutr Metab 2001 14 : 63 65.
15. Brown DW, Giles WH, Greenlund KJ, Valdez R, Croft JB. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QTc duration. Results from the Third National Health and Nutrition Examination Survey. J Cardiovasc Risk 2001 8 : 227 233.
16. Lieb W, Voss C, Ortak J, Barantke M, Hengstenberg C, Loewel H, Holmer S, et al. Impact of diabetes on QT dynamicity in patients with and without myocardial infarction: The KORA Family Heart Study. Pacing Clin Electrophysiol 2007 30 (Suppl. 1 S183 S187.
17. Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes 1999 48 : 937 942.
18. El-Atat FA, Mc Farlane SI, Sowers JR, Bigger JT. Sudden cardiac death in patients with diabetes. Curr Diab Rep 2004 4 : 187 193.
19. Nesto RW. Correlation between cardiovascular disease and diabetes mellitus: Current concepts. Am J Med 2004 116 (Suppl. 5A 11S 22S.
20. Molon G, Targher G, Bertolini L, Costa A, Barbieri E, Zenari L. Measurement of microvolt T-wave alternans, a new arrhythmic risk stratification test, in type 2 diabetic patients without clinical cardiovascular disease. Diabet Med 2006 23 : 207 210.
21. Chen-Scarabelli C, Scarabelli TM. Suboptimal glycemic control, independently of QT interval duration, is associated with increased risk of ventricular arrhythmias in a high-risk population. Pacing Clin Electrophysiol 2006 29 : 9 14.
22. Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications. Endocr Rev 2004 25 : 543 567.
23. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation 2007 115 : 387 397.